- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02048514
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
March 5, 2021 updated by: Endologix
The purpose of this clinical study is to evaluate the safety and device performance of the Nellix® EndoVascular Aneurysm Sealing System (Nellix System) for the treatment of infrarenal abdominal aortic aneurysms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a multicenter, multi-country prospective, single-arm, non-randomized clinical trial.
The comparative control arm is a combination of patient data drawn from the abdominal aortic aneurysms (AAA) open surgical control arms of four commercially approved AAA devices as part of the Society of Vascular Surgeons.
Patients enrolled in this study will be pre-screened and have a diagnosis of an infrarenal AAA with or without the need for treatment of iliac artery aneurysm, are candidates for endovascular repair, and meet the eligibility criteria.
Patients enrolled in the study will participate in follow-up visits 31 days, 6 months and at 1 year following the index procedure.
At the follow-up visits there will be a clinical assessment, blood collection, and abdominal CT imaging of the patient.
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cali, Colombia, 24-157
- Centro Medico de Cali
-
-
-
-
-
Riga, Latvia, LV-1007
- Paul Stradins University Hospital
-
-
-
-
-
Auckland, New Zealand, 1142
- Auckland City Hospital
-
-
-
-
-
Caracas, Venezuela
- Instituto de Clinicas Y Urologica Tomanaco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least 18 years of age
- Informed consent form understood and signed and patient agrees to all follow-up visits
- Is able and willing to comply with clinical follow-up requirements for one year
- Is able and willing to undergo Contrast-Enhanced Spiral CT scans
Is a candidate for endovascular repair of an infrarenal aortic aneurysm with or without an iliac aneurysm with at least one of the following;
- aneurysm ≥ 4.5 cm in diameter, or
- aneurysm is twice the diameter of the normal infrarenal aorta, or
- aneurysm is growing at a rate of ≥ 10 % per year
- Non-aneurysmal aortic neck length ≥ 5mm below the most inferior renal artery
- Proximal aortic neck diameter between 16 and 36mm
- Aortic neck angulation to the sac ≤ 60
- Common iliac artery diameter 8 to 35mm bilaterally
- Aneurysm blood lumen diameter ≤ 60mm
- Iliac and femoral arteries suitable for endovascular access with the Nellix System
Exclusion Criteria:
- Life expectancy ≤ 1 year
- Dissecting, ruptured, or leaking aneurysm (blood outside the aorta), has sustained recent trauma, is symptomatic, or is non-degenerative
- Aneurysm is thoraco-abdominal, suprarenal and/or mycotic
- Thoracic aneurysm ≥ 4.5cm in diameter
- AAA requires treatment that would result in bilateral occlusion of the internal iliac arteries
- Presence of mural thrombus > 50% circumferentially in aortic neck
- Iliac aneurysm blood lumen diameter > 35mm
- Active infection, vasculitis, or systemic connective tissue disease (e.g., Rheumatoid arthritis, scleroderma, Marfan's syndrome, Ehlers-Danlos disease) at time of procedure
- History of prior treatment of abdominal aortic or iliac artery aneurysm disease
- Femoral or iliac artery occlusive disease such that device delivery is not possible
- Vascular access for delivery of device requires placement of vascular conduit or is through an established vascular graft
- Receiving dialysis
- History of hypercoagulability
- Allergy to IV contrast
- Serum creatinine level >2.0 mg/dL (or equivalent)
- Patient is pregnant or nursing
- Patient is currently enrolled in an investigational drug or device trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Nellix Aneurysm Sealing
The Nellix® EndoVascular Aneurysm Sealing System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety- Number of Major Adverse Events
Time Frame: 30 day
|
The primary safety endpoint is defined as the incidence of Major Adverse Events (MAE) through 30 days after the index procedure.
|
30 day
|
Device Performance
Time Frame: 30 days
|
The primary performance endpoint is technical success defined as successful delivery and deployment of the device and freedom from open surgical conversion at 30 days.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All Cause Mortality
Time Frame: 12 months
|
Any death occurring during the study period, regardless of cause
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (ACTUAL)
December 1, 2017
Study Completion (ACTUAL)
December 1, 2017
Study Registration Dates
First Submitted
January 27, 2014
First Submitted That Met QC Criteria
January 27, 2014
First Posted (ESTIMATE)
January 29, 2014
Study Record Updates
Last Update Posted (ACTUAL)
March 9, 2021
Last Update Submitted That Met QC Criteria
March 5, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N09-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Aortic Aneurysms
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac AneurysmsUnited States, Canada
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States, China, Germany, Sweden, Russian Federation
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Cook Group IncorporatedNo longer availableAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States
-
Cook Group IncorporatedApproved for marketingAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Rijnstate HospitalW.L.Gore & AssociatesActive, not recruitingAneurysm | Abdominal Aortic Aneurysms | Common Iliac AneurysmsItaly, New Zealand, Netherlands, Spain
-
Endospan Ltd.CompletedAortoiliac Aneurysms | Infrarenal Abdominal Aortic AneurysmsItaly, Serbia, Netherlands, Switzerland
-
Gustavo OderichCook Group IncorporatedRecruitingJuxtarenal Aortic Aneurysms | Suprarenal Aortic Aneurysms | Type IV Thoracoabdominal Aortic AneurysmsUnited States
-
University of WashingtonRecruiting
-
Medtronic CardiovascularCompletedAbdominal Aortic AneurysmsUnited States
Clinical Trials on The Nellix® EndoVascular Aneurysm Sealing System
-
EndologixActive, not recruitingAbdominal Aortic AneurysmNew Zealand, Spain, Germany, Netherlands
-
Rijnstate HospitalWithdrawnInflammatory Response | Abdominal Aortic AneurysmNew Zealand, Netherlands, Spain, Germany, Poland
-
Galaxy Therapeutics INCNot yet recruiting
-
Stryker NeurovascularCompletedIntracranial AneurysmsUnited States, Germany, Canada, Spain, Norway, Australia, China, France, Mexico, Turkey, United Kingdom
-
Cook Group IncorporatedNo longer availableAorto-iliac Aneurysms | Iliac AneurysmsUnited States
-
EndologixActive, not recruitingAbdominal Aortic Aneurysm Without RuptureUnited States
-
EndologixActive, not recruiting1 Paravisceral Abdominal Aortic Aneurysm | 2 Juxtarenal Abdominal Aortic Aneurysm | 3 Pararenal Abdominal Aortic Aneurysm | 4 Complex Abdominal Aortic AneurysmsUnited States
-
Rijnstate HospitalMedtronicRecruitingAortic Aneurysm, AbdominalNetherlands, United States
-
Medtronic CardiovascularTerminated
-
Medtronic CardiovascularCompletedAbdominal Aortic AneurysmsUnited States